The venetoclax-based regimen was associated with an approximate $8000 decrease in costs compared with the continuous Bruton ...

The long-term response rate for zanubrutinib was better than ibrutinib in patients with relapsed/refractory chronic ...

Stand Up To Cancer® (SU2C) today announced a collaboration with Johnson & Johnson aimed at supporting research testing a ...

It can be challenging to detect CLL early because it does not cause symptoms in its early stages. CLL can follow two different patterns. Some forms develop very slowly, meaning a person may not ...

Expert Rev Hematol. 2013;6(4):441-449. In conclusion, although age should generally determine the goal of treatment in CLL, the patient's functional status rather than chronological age can be ...

Data are now accumulating on the feasibility of various treatment options even in unfit patients and there is an increased awareness that the chronological age by itself sometimes does not reflect ...

(NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across a range of B-cell malignancies and assets, including best-in-class Bruton’s tyrosine ...

But no single test can diagnose B-PLL, and a doctor can’t make a diagnosis on your symptoms alone. B-PLL is very similar to other types of blood cancers, such as CLL and mantle cell lymphoma (MCL).

Eric Manes first appeared in the Discovery Channel (USA) docudrama Moonshiners, which premiered on December 6, 2011. Moonshine is alcohol distilled illegally in the United States.

BeiGene (BGNE) announced it will share new data across a range of B-cell malignancies and assets, including Bruton’s tyrosine kinase, or ...

SEQ is the first and only assay to receive Medicare coverage for MRD assessment in MCLCoverage leverages new Medicare episode pricing ...

Emotional support from friends significantly enhances resilience during cancer treatment, providing comfort and ... As a ...